{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:31:04Z","timestamp":1770895864290,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>abesia microti<\/jats:italic>, an intraerythrocytic parasite, has been implicated in transfusion transmission. <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> seroprevalence in Connecticut (<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>) blood donors is approximately 1%; however, it is not known what percentage of donors is parasitemic and poses a risk for transmitting infection. Therefore, we determined the prevalence of demonstrable <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic>\u2005<jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> in donors from a highly endemic area of <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> and compared observed rates with concurrent immunofluorescence assay (<jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content>) testing results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p>Blood samples from consenting donors in southeastern <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> were collected from mid\u2010<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ugust through early <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>ctober 2009 and tested by <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content> for immunoglobulin <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content> antibodies and real\u2010time polymerase chain reaction (<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>) for <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic>\u2005<jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content> specificity was determined using blood donor samples collected in northwestern Vermont (<jats:styled-content style=\"fixed-case\">VT<\/jats:styled-content>), an area nonendemic for <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>abesia<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1002 <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> donors, 25 (2.5%) were <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content> positive and three (0.3%) were real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> positive. Among the three real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2013positive donors, two were also <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content> positive, while one was <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content> negative and may represent a window period infection. The two <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content>\u2010 and real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2013positive donors appeared to subsequently clear infection. The other real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2013positive donor did not provide follow\u2010up samples. Of 1015 <jats:styled-content style=\"fixed-case\">VT<\/jats:styled-content> donors tested by <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content>, only one (0.1%) was positive, but may have acquired infection during travel to an endemic area.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We prospectively identified several real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2013positive blood donors, including an <jats:styled-content style=\"fixed-case\">IFA<\/jats:styled-content>\u2010negative real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2013positive donor, in an area highly endemic for <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic>. These results suggest the need to include nucleic acid testing in planned mitigation strategies for <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.12125","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T22:25:53Z","timestamp":1362090353000},"page":"2644-2649","source":"Crossref","is-referenced-by-count":25,"title":["<i><scp>B<\/scp>abesia microti<\/i> real\u2010time polymerase chain reaction testing of <scp>C<\/scp>onnecticut blood donors: potential implications for screening algorithms"],"prefix":"10.1111","volume":"53","author":[{"given":"Stephanie T.","family":"Johnson","sequence":"first","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Van Tassell","sequence":"additional","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tonnetti","sequence":"additional","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritchard G.","family":"Cable","sequence":"additional","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor P.","family":"Berardi","sequence":"additional","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Leiby","sequence":"additional","affiliation":[{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Farmington Connecticut"},{"name":"Biomedical Services Research Department, Northeast Division American Red Cross  Farmington Connecticut"},{"name":"Transmissible Diseases Department American Red Cross Holland Laboratory  Rockville Maryland"},{"name":"Research Division Imugen  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202018"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00022-10"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00362"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02317.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02380.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03345.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00609.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02430.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.923"},{"key":"e_1_2_8_11_1","unstructured":"Vermont Department of Health.Babesiosis.2012. [cited 2012 May 15]. Available from: URL:http:\/\/healthvermont.gov\/prevent\/zoonotic\/tickborne\/Babesiosis.aspx"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03612.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.en.30.010185.002255"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00011-06"},{"key":"e_1_2_8_15_1","volume-title":"Standards for blood banks and transfusion services","author":"American Association of Blood Banks","year":"2011"},{"key":"e_1_2_8_16_1","first-page":"204A","article-title":"Babesia microti tests for blood donor screening","volume":"51","author":"Devine PBV","year":"2011","journal-title":"Transfusion"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00174.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02195.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.2.210"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/591467"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040085"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00204.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12125","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T10:24:53Z","timestamp":1696155893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/trf.12125"],"URL":"https:\/\/doi.org\/10.1111\/trf.12125","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}